Connect with us

Published

on

Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023. 

Jordan Vonderhaar | Bloomberg | Getty Images

All seven independent directors of 23andMe resigned from the company’s board Tuesday, a move that CEO Anne Wojcicki said left her “surprised and disappointed,” according to a memo to employees.

Wojcicki, who co-founded 23andMe in 2006, said she remains committed to taking the company private.

The genetic-testing company went public in 2021 through a special purpose acquisition company (SPAC), and the share price has been mostly in freefall since then, dropping more than 95% from its high. The directors formed a special committee in late March to explore potential paths forward.

Wojcicki submitted a proposal to take the company private in July, but it was rejected by the special committee, in part because it didn’t provide a premium to the closing price of 40 cents per share at the time.

In a letter to Wojcicki on Tuesday, the directors said they had yet to see a “fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders.” The directors said they disagree with Wojcicki about the “strategic direction for the company,” so they decided to resign effective immediately.

“That we have not seen any notable progress over the last 5 months leads us to believe no such proposal is forthcoming,” they wrote. “The Special Committee is therefore unwilling to consider further extensions, and the Board agrees with the Special Committee’s determination.”

Wojcicki wrote in the employee memo, which was viewed by CNBC, that she still sees taking 23andMe private as its “best opportunity for long term success.” The company will begin a search for new independent directors to join the board, she added.

Far from its onetime valuation of $3.5 billion, 23andMe now has a market cap of under $200 million. The shares closed at 34 cents on Tuesday.

Here’s Wojcicki’s full memo:

Team 23,

We wanted to let you know that the 23andMe Board issued a press release this afternoon stating that all of the independent directors have resigned from the Board, effective immediately.

I am surprised and disappointed by the decision of the directors to resign.    

I have been committed to the mission of 23andMe for the last 18 years and believe strongly in the potential for genetic information to transform healthcare and the therapeutic discovery process. I remain committed to our customers, my employees and to our stockholders to achieve our goals.  I continue to believe that we will be better positioned to achieve our mission and goals outside of the short term pressures of the public markets and that taking 23andMe private will be the best opportunity for long term success. 

We will immediately begin identifying independent directors to join the board.  I want to thank the directors for their service to the company and its stockholders. 

I don’t have additional information to share at this time, but we will update as we can at Thursday’s Feisty.   

Anne

WATCH: 23andMe CEO files to take company private

23andMe CEO files proposal to take company private as stock craters

Continue Reading

Technology

Tokenization of real world assets is an unstoppable ‘freight train’ coming to major markets: Robinhood CEO

Published

on

By

Tokenization of real world assets is an unstoppable ‘freight train’ coming to major markets: Robinhood CEO

Vlad Tenev, chief executive officer of Robinhood Markets Inc., during the Token2049 conference in Singapore, on Thursday, Oct. 2, 2025.

Bloomberg | Bloomberg | Getty Images

The tokenization of real-world assets, from stocks to real estate, will spread to financial markets around the world, according to Robinhood Markets Chief Executive Officer Vlad Tenev. 

“Tokenization is like a freight train. It can’t be stopped, and eventually it’s going to eat the entire financial system,” Tenev told a panel at a crypto conference in Singapore on Wednesday. 

“I think most major markets will have some framework in the next five years,” he said, though he added that reaching 100% could take more than a decade.

A tokenized asset is a digital representation of a real-world asset, like stocks, bonds, or commodities, that can be recorded and traded on a blockchain or distributed ledger.

Robinhood CEO: Tokenization is going to 'eat the whole global financial system'

In June, Robinhood began offering more than 200 tokenized U.S. stocks to customers in the European Union, giving them a new way to gain exposure to the underlying assets. The move sent its stock surging to a then-record high.

“I think it will become the default way to get exposure to U.S. stocks outside the U.S.,” Tenev said. 

He expects the practice to gain traction once there is greater licensing and regulatory clarity in more jurisdictions.

“I think that will come, starting in Europe, but then expanding to the rest of the world,” he said.

On the other hand, Tenev expects the U.S. to be among the last economies to actually fully tokenize, due to what he calls the greater sticking power of the financial infrastructure. 

The crypto industry has long predicted that a mass tokenization of assets on the blockchain was coming, promising greater market efficiency. 

And, along with Robinhood’s launch of tokenized stocks, there’s been more signs this year that real implementation is coming, with institutional giants Morgan Stanley and BlackRock signaling interest. 

“I actually think cryptocurrency and traditional finance have been living in two separate worlds for a while, but they’re going to fully merge,” Tenev said at the event.

He cited stablecoins — digital currencies designed not to fluctuate wildly, and pegged to a commodity or a fiat currency like the U.S. dollar — as an early example of a tokenized real-world asset.

“I think that crypto technology has so many advantages over the traditional way we’re doing things that in the future there’s going to be no distinction,” Tenev said.

Continue Reading

Technology

Why current AI models won’t make scientific breakthroughs, according to a top tech exec

Published

on

By

Why current AI models won't make scientific breakthroughs, according to a top tech exec

Co-founder and Chief Science Officer at Hugging Face, Thomas Wolf, speaks at the opening ceremony of the Web Summit, in Lisbon, Portugal, November 11, 2024. 

Pedro Nunes | Reuters

Current artificial intelligence models from labs like OpenAI are unlikely to lead to major scientific breakthroughs, a tech co-founder said, pouring cold water on some of the hype around the technology and claims by major figures in the field.

The comments by Thomas Wolf, co-founder of $4.5 billion AI startup Hugging Face, are in stake contrast to those by major names in AI including OpenAI boss Sam Altman and Anthropic CEO Dario Amodei.

When Wolf talks about scientific breakthroughs, he means novel ideas like those at a Nobel Prize level. Examples including Nicolaus Copernicus who theorized the sun was at the center of the universe and other planets move round it.

Wolf explained a couple of issues with chatbots right now. The first is that these products like ChatGPT and others often agree or align with the person prompting it. Think back to if you’ve asked a chatbot a prompt and it will tell you how interesting or great that question is.

The second is that the models underpinning these chatbots are designed to “predict the most likely next token” or “word” in a sentence.

However, he noted two key traits of scientists. The first is that scientists who make major breakthroughs are often contrarian and question what others are saying.

“The scientist is not trying to predict the most likely next word. He’s trying to predict this very novel thing that’s actually surprisingly unlikely, but actually is true,” Wolf said.

The Hugging Face co-founder has been thinking about this topic for the last few months. His interest was sparked after he read an essay penned by Anthropic’s Amodei, who posited that “AI-enabled biology and medicine will allow us to compress the progress that human biologists would have achieved over the next 50-100 years into 5-10 years.”

That got Wolf thinking about the state of AI and how this won’t be possible, in his view, with the current crop of models.

Wolf said that these chatbots and tools will likely be used as a sort of “co-pilot for a scientist” where they are used for research to help the human generate new ideas.

To some extent, this has been happening already. Google DeepMind’s AlphaFold product has helped to analyze protein structures which the company has promised could aid scientists in discovering new drugs.

But there are some new startups that are hoping to take AI one step further into being able to make scientific breakthroughs, including Lila Sciences and FutureHouse.

Continue Reading

Technology

Taiwan rejects U.S. proposal for ’50-50′ chip production, says trade talks focused on tariffs

Published

on

By

Taiwan rejects U.S. proposal for '50-50' chip production, says trade talks focused on tariffs

Taiwan Semiconductor Manufacturing Company, Limited at Hsinchu Science Park.

Annabelle Chih | Getty Images News | Getty Images

Taiwan will not accept Washington’s proposal to locally manufacture half the chips it currently supplies to the U.S., the island’s top trade negotiator said.

Speaking to reporters, Cheng Li-chiun, also the country’s vice premier, said on Wednesday that the proposal for a “50-50” split in semiconductor production was not even discussed, as she returned from trade talks in the U.S., according to Taiwan’s Central News Agency.

Cheng said the talks were focused on lowering tariff rates, securing exemptions from tariff stacking — additional duties — and reducing levies on Taiwanese exports. Taiwan currently faces a “reciprocal” tariff rate of 20%.

Washington has held discussions with Taipei about the “50-50” split in semiconductor production, which would cut American reliance on Taiwan, Commerce Secretary Howard Lutnick said last weekend in an interview to NewsNation, adding that currently 95% of the U.S. demand was met via chips produced within Taiwan.  

“My objective, and this administration’s objective, is to get chip manufacturing significantly onshored — we need to make our own chips,” Lutnick said. “The idea that I pitched [Taiwan] was, let’s get to 50-50. We’re producing half, and you’re producing half.” 

U.S. President Donald Trump had also taken aim at the island’s dominance in chips earlier this year, accusing it of “stealing” the U.S.’ chip business.

The Office of the U.S. Trade Representative and Taiwan’s Ministry of Economic Affairs did not immediately respond to CNBC’s request for comments.

Lutnick’s proposal has been condemned by Taiwan’s politicians, with Eric Chu, chairman of the island’s principal opposition party Kuomintang, calling it “an act of exploitation and plunder,” according to the Central News Agency report.

“No one can sell out Taiwan or TSMC, and no one can undermine Taiwan’s silicon shield,” Chu said, referring to Taiwan Semiconductor Manufacturing Company, the world’s leader in advanced chip manufacturing.

Taiwan’s critical position in global chips production is believed to have assured the island nation’s defense against direct military action from China, often referred to as the “Silicon Shield” theory.

In his NewsNation interview, Lutnick downplayed the “Silicon Shield,” arguing that Taiwan would be safer with more balanced chip production between Washington and Taipei. Beijing views the democratically governed island of Taiwan as its own territory and has vowed to reclaim it by force if necessary, while Taipei rejects those claims

Taiwan People’s Party Chairman Huang Kuo-chang reportedly called Lutnick’s proposal an attempt to “hollow out the foundations of Taiwan’s technology sector.”

Continue Reading

Trending